Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Asset disposition
Quarterly results
Credit agrmnt [a]
CC transcript

AZIYO BIOLOGICS, INC. (AZYO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 HighCape Capital, LLC (10% Owner) has filed a Form 4 on ELUTIA INC.
Txns: Bought 2,837,128 shares @ $0
Bought 4,255,693 warrants @ $1.4275, valued at $6.1M
10/05/2023 4 HighCape Capital, L.P. (10% Owner) has filed a Form 4 on ELUTIA INC.
Txns: Bought 2,837,128 shares @ $0
Bought 4,255,693 warrants @ $1.4275, valued at $6.1M
06/12/2023 4 HighCape Capital, L.P. (10% Owner) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 37,500 options to buy @ $2.37, valued at $88.9k
Granted 25,000 options to buy @ $2.37, valued at $59.3k
06/12/2023 4 Makes Brigid (Director) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 25,000 options to buy @ $2.37, valued at $59.3k
06/12/2023 4 Colpman David (Director) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 25,000 options to buy @ $2.37, valued at $59.3k
06/12/2023 4 Jordan Maybelle (Director) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 25,000 options to buy @ $2.37, valued at $59.3k
04/28/2023 4 Mills C Randal (PRESIDENT AND CEO) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 134,840 restricted stock units @ $0
Exercised 44,947 restricted stock units @ $0
Granted 89,894 restricted stock units @ $0
03/27/2023 4 Birchview Capital, LP (10% Owner) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Bought 100,000 shares @ $1.491, valued at $149.1k
Bought 10,000 shares @ $1.491, valued at $14.9k
Bought 18,000 shares @ $1.3539, valued at $24.4k
Bought 2,000 shares @ $1.3539, valued at $2.7k
Bought 10,000 shares @ $1.587, valued at $15.9k
03/09/2023 4 Englese Thomas (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Sold 289 shares @ $4.3, valued at $1.2k
Exercised 937 restricted stock units @ $0
03/09/2023 4 Ferguson Matthew (CFO) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Exercised 1,287 restricted stock units @ $0
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2022 4 HighCape Partners GP II, LLC (10% Owner) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 17,533 options to buy @ $3.8, valued at $66.6k
12/27/2022 4 HighCape Capital, L.P. (10% Owner) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 17,533 options to buy @ $3.8, valued at $66.6k
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/12/2022 4 Ferguson Matthew (CFO) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Paid exercise price by delivering 4,798 shares @ $7.3, valued at $35k
Exercised 13,874 restricted stock units @ $0
09/12/2022 4 Edwards Peter G (GENERAL COUNSEL) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Paid exercise price by delivering 1,127 shares @ $7.3, valued at $8.2k
Exercised 4,625 restricted stock units @ $0
09/12/2022 4 Englese Thomas (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Paid exercise price by delivering 4,728 shares @ $7.3, valued at $34.5k
Exercised 15,390 restricted stock units @ $0
09/12/2022 4 Riebman Jerome (CHIEF MEDICAL OFFICER) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Paid exercise price by delivering 5,104 shares @ $7.3, valued at $37.3k
Exercised 14,758 restricted stock units @ $0
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Jordan Maybelle (Director) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 22,090 options to buy @ $6.28, valued at $138.7k
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/10/2022 4 Englese Thomas (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Sold 276 shares @ $0
Granted 31,000 options to buy @ $5.08, valued at $157.5k
Granted 8,700 restricted stock units @ $0
Exercised 938 restricted stock units @ $0
Granted 15,390 restricted stock units @ $0
03/10/2022 4 Roberts Darryl (EVP, OPERATIONS & PRODUCT DEV.) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 37,200 options to buy @ $5.08, valued at $189k
Granted 10,440 restricted stock units @ $0
Exercised 938 restricted stock units @ $0
Granted 17,024 restricted stock units @ $0
03/10/2022 4 LLOYD RONALD K. (PRESIDENT AND CEO) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 138,770 options to buy @ $5.08, valued at $705k
Granted 37,788 restricted stock units @ $0
Exercised 4,072 restricted stock units @ $0
Granted 39,894 restricted stock units @ $0
03/10/2022 4 Riebman Jerome (CHIEF MEDICAL OFFICER) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 31,000 options to buy @ $5.08, valued at $157.5k
Granted 8,700 restricted stock units @ $0
Exercised 782 restricted stock units @ $0
Granted 14,758 restricted stock units @ $0
03/10/2022 4 Ferguson Matthew (CFO) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 31,000 options to buy @ $5.08, valued at $157.5k
Granted 8,700 restricted stock units @ $0
Exercised 1,288 restricted stock units @ $0
Granted 13,874 restricted stock units @ $0
03/10/2022 4 Edwards Peter G (GENERAL COUNSEL) has filed a Form 4 on AZIYO BIOLOGICS, INC.
Txns: Granted 31,000 options to buy @ $5.08, valued at $157.5k
Granted 8,700 restricted stock units @ $0
Granted 4,625 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy